Serotonin (5-HT) is pruritogenic in humans and suggested to be involved in
some pruritic diseases. Our experiments were carried out to determine wheth
er an intradermal injection of 5-HT would elicit itch-associated response i
n mice and to elucidate the 5-HT receptor subtypes involved in this 5-HT ac
tion. 5-HT (14.1-235 nmol site(-1)) injected intradermally into the rostral
back elicited scratching of the injected site, with bell-shaped dose-respo
nse relationship. The scratching induced by 5-HT (100 nmol site(-1), peak e
ffective dose) was suppressed by capsaicin (repeated administration) and th
e opioid antagonist naloxone, features being similar to human itching. Scra
tching was also elicited, by the 5-HT2 receptor agonist alpha-methylseroton
in, but not by the 5-HT1A receptor agonist R(+)-8-hydroxy-N,N-dipropyl-2-am
inotetralin nor the 5-HT3 receptor agonists 2-methylserotonin and 1- phenyl
biganide, Scratching induced by 5-HT and alpha-methylserotonin was inhibite
d by peroral pretreatment with 5-HT1/2 receptor antagonists methysergide an
d cyproheptadine. 5-HT-induced scratching was also inhibited by intradermal
injection of methysergide. Peroral pretreatment with 5-HT3 receptor antago
nists ondansetron and 3-tropanyl-3, 5-dichrobenzoate did not significantly
suppress 5-HT-induced scratching. The results suggest that scratching induc
ed by intradermal injection of 5-HT is itch-associated response. The 5-HT a
ction may be mediated at least partly by cutaneous 5-HT2 receptors. (C) 199
9 Elsevier Science Ireland Ltd. an rights reserved.